Stuttgart, 14 May 2014

Transcription

1 Half-year Press Conference Stuttgart, Dr. Michael Kaschke President & CEO Thomas Spitzenpfeil Chief Financial Officer

2 Dr. Michael Kaschke President & CEO Thomas Spitzenpfeil Chief Financial Officer 2

3 Overview 2013/14 1 st Half-year 2013/ /13 in EUR million +/ Comparable* Incoming orders 2,246 1, % +19% Revenue 2,074 1,978 +5% +7% EBIT (Earnings before Interest and Taxes) million +77 million Consolidated profit/loss million 31 March March 2013 Employees 24,791 24,803 +/-0% *The comparably calculated values in this presentation have been adjusted to allow for changes on the basis of consolidation and for currency effects. 3

4 Revenue distribution Around 90% of revenue is generated outside Germany Collaborations 460 million +40.8% EMEA 717 million +2.4%* Germany 256 million +5.1% Revenue trend of direct business in March emerging markets million -3% (+8%*) Americas 478 million 12.0%* *Comparable. APAC 419 million +15.4%* 2012/ /14 4

5 Industrial Metrology business group Ongoing growth new products generate momentum 2 nd half year Revenue 271 million +2% (+5%*) / /14 *Comparable. 5

6 Microscopy business group Stable further growth opportunities 2 nd half year Revenue 314 million +4% (+2%*) / /14 *Comparable. 6

7 Medical Technology business group Climbing revenue intraocular lens business expanded 2 nd half year 1, Revenue 510 million +3% (+9%*) / /14 *Comparable. The values deviate from the published figures of Carl Zeiss Meditec AG as a result of different consolidation models. 7

8 Vision Care business group Results of operations declining revenue due to loss of major order 841 Revenue 2 nd half year million -8% (-4%*) / /14 *Comparable. 8

9 Consumer Optics business group Reserved demand for camera lenses and binoculars 195 Revenue 2 nd half year million -6% (-4%*) / /14 *Comparable. 9

10 Semiconductor Manufacturing Technology business group Clear revenue growth despite delay in EUV nd half year 542 Revenue 499 million +27% / /14 10

11 Expenditure on research and development 10% of revenue goes to research focus on fast release to market nd half year million +10% / /14 11

12 Investments in property, plant and equipment At normal level following investment push in prior year nd half year million -40 million / /14 Investments in property, plant and equipment Depreciation of property, plant and equipment 12

13 Free cashflow and EBIT Cashflow clearly increased over prior year EBIT 2 nd half year 292 Free cash flow Mio. +57 million million +135 million / / / /13 13

14 Gross and net liquidity Good liquidity despite acquisitions and negative currency effects million -83 million 128 Gross liquidity Net liquidity 30 September March

15 Equity Pension provisions and currency effects having a negative impact 1,232* 1,128 1,182 million -4% Equity ratio 24% 30 September 2013 *Revised. in accordance with IAS March

16 Overall forecast for 2013/14 Cautious optimism Economic stagnation and political unrest in several regions Exchange rates and deteriorating growth dynamic in the emerging markets Ambitious goal remains in focus Increase in revenue and earnings in fiscal year 2013/14 remain realistic Accepting global challenges Optimization of structures and processes, as well as the acceleration of innovations to be able to react quickly to markets and the economy. 16

17 Contact If you have any questions, please do not hesitate to contact Jörg Nitschke Corporate Communications Phone +49 (0) 7364/

18